CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability

Tong, Jiefei, Sydorskyy, Yaroslav, St-Germain, Jonathan R., Taylor, Paul, Tsao, Ming S., Moran, Michael F.·2013·PLoS ONE
DOI 10.1371/journal.pone.0064817PMC PMC3692516
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0064817

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ligand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes.

    “Since AP-1 has been shown to localize to Rab11-positive recycling endosomes [28], and ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes [29, 30], we examined if three molecules, EGFR, AP-1, and Rab11, could show colocalization in the cytoplasm.”

    From Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth (2021) · cites this paper as [29]

  • Ligand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes, promoted by the short form of EPS15 and Odin.

    “Previous studies have demonstrated that ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes, which is promoted by the short form of EPS15 [30] and a tyrosine-phosphorylated component, Odin [29, 30].”

    From Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth (2021) · cites this paper as [29]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. J Schlessinger, 2002, Ligand-induced, receptor-mediated dimerization and activation of EGF receptor, Cell, 110, 669, 10.1016/S0092-8674(02)00966-2 · DOI
  2. Y Yarden, 2001, The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities, Eur J Cancer, 37, S3, 10.1016/S0959-8049(01)00230-1 · DOI
  3. A Sorkin, 2008, Endocytosis and intracellular trafficking of ErbBs, Exp Cell Res, 314, 3093
  4. MV Grandal, 2008, Epidermal Growth Factor Receptor and Cancer: Control of Oncogenic Signalling by Endocytosis, J Cell Mol Med, 12, 1527, 10.1111/j.1582-4934.2008.00298.x · DOI
  5. S Sebastian, 2006, The complexity of targeting EGFR signalling in cancer: from expression to turnover, Biochim Biophys Acta, 1766, 120
  6. A Kirisits, 2007, Epidermal growth factor receptor degradation: An alternative view of oncogenic pathways, Int J Biochem Cell Biol, 39, 2173, 10.1016/j.biocel.2007.07.012 · DOI
  7. S Thomson, 2005, Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition, Cancer Res, 65, 9455, 10.1158/0008-5472.CAN-05-1058 · DOI
  8. T Pawson, 2004, Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems, Cell, 116, 191, 10.1016/S0092-8674(03)01077-8 · DOI
  9. J Dengjel, 2007, Quantitative proteomic assessment of very early cellular signaling events, Nat Biotechnol, 25, 566, 10.1038/nbt1301 · DOI
  10. SV Sharma, 2007, Epidermal growth factor receptor mutations in lung cancer, Nat Rev Cancer, 7, 169, 10.1038/nrc2088 · DOI · Paper page
  11. B Schoeberl, 2009, Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis, Sci Signal, 2, ra31, 10.1126/scisignal.2000352 · DOI
  12. DR Mattoon, 2004, The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway, BMC Biol, 2, 24, 10.1186/1741-7007-2-24 · DOI
  13. EJ Lowenstein, 1992, The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling, Cell, 70, 431, 10.1016/0092-8674(92)90167-B · DOI
  14. Z Wang, 1996, Requirement for the adapter protein GRB2 in EGF receptor endocytosis, Science, 272, 1935, 10.1126/science.272.5270.1935 · DOI
  15. F Huang, 2005, Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis, Mol Biol Cell, 16, 1268, 10.1091/mbc.E04-09-0832 · DOI
  16. H Waterman, 2002, A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling, Embo J, 21, 303, 10.1093/emboj/21.3.303 · DOI
  17. P Woodman, 2009, ESCRT proteins, endosome organization and mitogenic receptor down-regulation, Biochem Soc Trans, 37, 146, 10.1042/BST0370146 · DOI
  18. J Tong, 2009, Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041, Mol Cell Proteomics, 8, 2131, 10.1074/mcp.M900148-MCP200 · DOI
  19. B Blagoev, 2004, Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics, Nat Biotechnol, 22, 1139, 10.1038/nbt1005 · DOI
  20. Y Zhang, 2005, Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules, Mol Cell Proteomics, 4, 1240, 10.1074/mcp.M500089-MCP200 · DOI
  21. A Wolf-Yadlin, 2007, Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks, Proc Natl Acad Sci U S A, 104, 5860, 10.1073/pnas.0608638104 · DOI
  22. SL Wu, 2006, Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA), Mol Cell Proteomics, 5, 1610, 10.1074/mcp.M600105-MCP200 · DOI
  23. JV Olsen, 2006, Global, in vivo, and site-specific phosphorylation dynamics in signaling networks, Cell, 127, 635, 10.1016/j.cell.2006.09.026 · DOI
  24. H Imamura, 2010, Towards the systematic discovery of signal transduction networks using phosphorylation dynamics data, BMC Bioinformatics, 11, 232, 10.1186/1471-2105-11-232 · DOI
  25. F Gnad, 2011, PHOSIDA 2011: the posttranslational modification database, Nucleic Acids Res, 39, D253, 10.1093/nar/gkq1159 · DOI
  26. K Roepstorff, 2009, Differential effects of EGFR ligands on endocytic sorting of the receptor, Traffic, 10, 1115, 10.1111/j.1600-0854.2009.00943.x · DOI · Paper page
  27. A Sorkin, 2009, Endocytosis and intracellular trafficking of ErbBs, Exp Cell Res, 315, 683, 10.1016/j.yexcr.2008.07.029 · DOI
  28. YN Wang, 2010, Nuclear trafficking of the epidermal growth factor receptor family membrane proteins, Oncogene, 29, 3997, 10.1038/onc.2010.157 · DOI
  29. IH Madshus, 2009, Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking, J Cell Sci, 122, 3433, 10.1242/jcs.050260 · DOI
  30. K Roepstorff, 2008, Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer, Histochem Cell Biol, 129, 563, 10.1007/s00418-008-0401-3 · DOI
  31. Y Mosesson, 2008, Derailed endocytosis: an emerging feature of cancer, Nat Rev Cancer, 8, 835, 10.1038/nrc2521 · DOI
  32. P Singhirunnusorn, 2007, Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway, J Biol Chem, 282, 12698, 10.1074/jbc.M608723200 · DOI
  33. SE Winograd-Katz, 2006, Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor, Oncogene, 25, 7381, 10.1038/sj.onc.1209737 · DOI
  34. Y Zwang, 2006, p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy, Embo J, 25, 4195, 10.1038/sj.emboj.7601297 · DOI
  35. A Pandey, 2002, Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases, Oncogene, 21, 8029, 10.1038/sj.onc.1205988 · DOI
  36. M Emaduddin, 2008, Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells, Cell Commun Signal, 6, 7, 10.1186/1478-811X-6-7 · DOI
  37. TZ Kristiansen, 2004, Mouse embryonic fibroblasts derived from Odin deficient mice display a hyperproliiferative phenotype, DNA Res, 11, 285
  38. RB Jones, 2006, A quantitative protein interaction network for the ErbB receptors using protein microarrays, Nature, 439, 168, 10.1038/nature04177 · DOI
  39. A Sorkin, 1996, Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif, J Biol Chem, 271, 13377, 10.1074/jbc.271.23.13377 · DOI
  40. D Stover, 2004, Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts, Clinical Proteomics, 1, 69, 10.1385/CP:1:1:069 · DOI
  41. J Zhong, 2011, The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC, J Proteomics, 74, 294, 10.1016/j.jprot.2010.11.006 · DOI
  42. H Kajiho, 2012, RINL, guanine nucleotide exchange factor Rab5-subfamily, is involved in the EphA8-degradation pathway with odin, PLoS One, 7, e30575, 10.1371/journal.pone.0030575 · DOI
  43. J Kim, 2010, The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors, Mol Cell Biol, 30, 1582, 10.1128/MCB.01605-09 · DOI
  44. J Shin, 2007, Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function, Mol Cell Biol, 27, 8113, 10.1128/MCB.00794-07 · DOI
  45. FA Mercurio, 2012, Solution Structure of the First Sam Domain of Odin and Binding Studies with the EphA2 Receptor, Biochemistry, 51, 2136, 10.1021/bi300141h · DOI
  46. J Tong, 2008, Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor, J Proteome Res, 7, 1067, 10.1021/pr7006363 · DOI
  47. AL Barlow, 2010, Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of pearson's correlation coefficient, Microsc Microanal, 16, 710, 10.1017/S143192761009389X · DOI
  48. A Baldys, 2009, Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor, Biochemistry, 48, 1462, 10.1021/bi801771g · DOI
  49. B MacLean, 2010, Skyline: an open source document editor for creating and analyzing targeted proteomics experiments, Bioinformatics, 26, 966, 10.1093/bioinformatics/btq054 · DOI · Paper page
  50. B Maclean, 2010, Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry, Anal Chem, 82, 10116, 10.1021/ac102179j · DOI
  51. MC Willingham, 1983, The morphologic pathway of binding and internalization of epidermal growth factor in cultured cells. Studies on A431, KB, and 3T3 cells, using multiple methods of labelling, Exp Cell Res, 146, 163, 10.1016/0014-4827(83)90334-8 · DOI
  52. KE Longva, 2002, Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies, J Cell Biol, 156, 843, 10.1083/jcb.200106056 · DOI
  53. MV Kharchenko, 2007, Epidermal growth factor (EGF) receptor endocytosis is accompanied by reorganization of microtubule system in HeLa cells, Cell Biol Int, 31, 349, 10.1016/j.cellbi.2007.01.020 · DOI
  54. BS Stein, 1984, Complete inhibition of transferrin recycling by monensin in K562 cells, J Biol Chem, 259, 14762, 10.1016/S0021-9258(17)42668-8 · DOI
  55. LP Sousa, 2012, Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane, Proc Natl Acad Sci U S A, 109, 4419, 10.1073/pnas.1200164109 · DOI
  56. O Ullrich, 1996, Rab11 regulates recycling through the pericentriolar recycling endosome, J Cell Biol, 135, 913, 10.1083/jcb.135.4.913 · DOI · Paper page
  57. D Teis, 2003, The odd couple: signal transduction and endocytosis, Cell Mol Life Sci, 60, 2020, 10.1007/s00018-003-3010-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Tong, J., Sydorskyy, Y., St-Germain, J. R., Taylor, P., Tsao, M. S., & Moran, M. F.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2013-06-25
Volume
8
Issue
6
Pages
e64817
ISSN
1932-6203
DOI
10.1371/journal.pone.0064817
PMC
PMC3692516
Cited by
25
References
3
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review